Superparamagnetic nanoparticles for biomedical applications:: Possibilities and limitations of a new drug delivery system

被引:1406
作者
Neuberger, T
Schöpf, B
Hofmann, H
Hofmann, M
von Rechenberg, B
机构
[1] Univ Zurich, Fac Vet, Musculoskeletal Res Unit, CH-8057 Zurich, Switzerland
[2] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Inst Mat, Lab Powder Technol, CH-1015 Lausanne, Switzerland
[3] MatSearch Pully, CH-1009 Pully, Switzerland
关键词
superparamagnetic iron oxide nanoparticles (SPION); nanoparticles; magnetic drug targeting (MDT); immunomagnetic cell sorting (IMS); magnetic hyperthermia; toxicity; hyperthermia; review; contrast agent; nanoparticle functionalization; nanoparticle application;
D O I
10.1016/j.jmmm.2005.01.064
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Nanoparticles can be used in biomedical applications, where they facilitate laboratory diagnostics, or in medical drug targeting. They are used for in vivo applications such as contrast agent for magnetic resonance imaging (MRI), for tumor therapy or cardiovascular disease. Very promising nanoparticles for these applications are superparamagnetic nanoparticles based on a core consisting of iron oxides (SPION) that can be targeted through external magnets. SPION are coated with biocompatible materials and can be functionalized with drugs, proteins or plasmids. In this review, the characteristics and applications of SPION in the biomedical sector are introduced and discussed. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:483 / 496
页数:14
相关论文
共 143 条
[1]  
Abe Y, 2000, Radiat Med, V18, P97
[2]  
Alexiou C, 2000, CANCER RES, V60, P6641
[3]  
Allen LM, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P481
[4]   Practice guidelines in the management of osteoarthritis [J].
Altman, RD ;
Lozada, CJ .
OSTEOARTHRITIS AND CARTILAGE, 1998, 6 :22-24
[5]   Human serum albumin as a probe for protein adsorption to nanoparticles: Relevance to biodistribution [J].
Armstrong, TI ;
Davies, MC ;
Illum, L .
JOURNAL OF DRUG TARGETING, 1997, 4 (06) :389-398
[6]   MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles [J].
Artemov, D ;
Mori, N ;
Okollie, B ;
Bhujwalla, ZM .
MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (03) :403-408
[7]   Synthesis of iron oxide nanoparticles used as MRI contrast agents: A parametric study [J].
Babes, L ;
Denizot, B ;
Tanguy, G ;
Le Jeune, JJ ;
Jallet, P .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1999, 212 (02) :474-482
[8]  
Bacri JC, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P597
[9]   Colloidal drug carriers: achievements and perspectives [J].
Barratt, G .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (01) :21-37
[10]  
Barratt G, 2002, POLYM BIOMATERIALS, P753